{"_links": {"parentPackage": {"href": "/mdr/ct/packages/protocolct-2023-06-30", "title": "Protocol Controlled Terminology Package 54 Effective 2023-06-30", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/protocolct-2023-03-31/codelists/C187683", "title": "CDISC Protocol Expanded Access Study Type Value Set Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/protocolct/codelists/C187683", "title": "Version-agnostic anchor resource for codelist C187683", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/protocolct-2023-06-30/codelists/C187683", "title": "CDISC Protocol Expanded Access Study Type Value Set Terminology", "type": "Code List"}}, "conceptId": "C187683", "definition": "The terminology relevant to the type of expanded access study.", "name": "Expanded Access Study Type Value Set Terminology", "preferredTerm": "CDISC Protocol Expanded Access Study Type Value Set Terminology", "submissionValue": "Expanded Access Study Type Value Set Terminology", "synonyms": ["Expanded Access Study Type Value Set Terminology"], "terms": [{"conceptId": "C187706", "definition": "Expanded access to an investigational medical product (drug, biologic, or medical device) for treatment use in subjects after the controlled clinical trial has been completed and while the marketing application is being prepared by the sponsor or reviewed by the regulator.", "preferredTerm": "Continued Access Study", "submissionValue": "Continued Access"}, {"conceptId": "C182399", "definition": "Expanded access to an investigational medical product (drug, biologic, or medical device) for treatment use by a single patient submitted under a new Investigational New Drug (IND) application. (FDA: Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers Guidance for Industry, June 2016)", "preferredTerm": "Compassionate Single Patient Indicator", "submissionValue": "Individual Patient IND", "synonyms": ["Individual Basis Treatment", "Single Patient IND"]}, {"conceptId": "C187707", "definition": "Expanded access to an investigational medical product (drug, biologic, or medical device) for treatment use by a large (widespread) population, submitted under a new Investigational New Drug (IND) application. (FDA: Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers Guidance for Industry, June 2016)", "preferredTerm": "Treatment Investigational New Drug Study", "submissionValue": "Treatment IND", "synonyms": ["Expanded Access Treatment IND", "Large Population Treatment IND"]}]}